MyFinsight
Home
Blog
About
Cash and cash
equivalents
$12,860K
(33.94%↑ Y/Y)
Short-term investments
$4,738K
(-81.17%↓ Y/Y)
Prepaid expenses and
other current assets
$2,766K
(-0.61%↓ Y/Y)
Restricted cash
$200K
(-74.49%↓ Y/Y)
Total current assets
$20,564K
(-46.36%↓ Y/Y)
Operating lease
right-of-use assets
$17,075K
(-16.78%↓ Y/Y)
Restricted cash,
non-current
$1,538K
(56.78%↑ Y/Y)
Property and equipment,
net
$571K
(-66.76%↓ Y/Y)
Long-term investments
$509K
(-96.29%↓ Y/Y)
Other assets
$87K
(-60.81%↓ Y/Y)
Total assets
$40,344K
(-46.56%↓ Y/Y)
Total liabilities and
stockholders' equity
$40,344K
(-46.56%↓ Y/Y)
Total liabilities
$27,704K
(-24.42%↓ Y/Y)
Total stockholders'
equity
$12,640K
(-67.46%↓ Y/Y)
Accumulated deficit
-$475,743K
(-6.43%↓ Y/Y)
Accumulated other
comprehensive loss
-$44K
(-633.33%↓ Y/Y)
Operating lease
liabilities, net of current...
$18,533K
(-14.29%↓ Y/Y)
Total current
liabilities
$7,867K
(-36.09%↓ Y/Y)
Deferred revenue,
non-current
$1,172K
(-54.75%↓ Y/Y)
Other long-term
liabilities
$132K
(-0.75%↓ Y/Y)
Additional paid-in capital
$488,427K
(0.53%↑ Y/Y)
Operating lease
liabilities
$3,091K
(20.79%↑ Y/Y)
Accrued expenses and
other current...
$3,089K
(-42.66%↓ Y/Y)
Accounts payable
$868K
(-53.13%↓ Y/Y)
Deferred revenue
$819K
(-67.40%↓ Y/Y)
Back
Back
Balance Sheet
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)
source: myfinsight.com